SAHA SAURABH

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$1.01M
Insider Sells Quantity
20
Insider Sells Sum
$12.31M

Insider Activity of SAHA SAURABH

According to the SEC Form 4 filings, SAHA SAURABH, being in a position of

  1. Chief Executive Officer at Centessa Pharmaceuticals plc,
    оver the last 12 months, has bought 0 shares, and sold 740000 shares for $12.19M,
    over all time since 2021-11-16, has bought 76000 shares for $754,912, and sold 740000 shares for $12.19M.

The largest purchase of all time was on 2021-11-16 and amounted to 46000 shares of Centessa Pharmaceuticals plc for $564,944.

The largest sale of all time was on 2024-09-10 and amounted to 175000 shares of Centessa Pharmaceuticals plc for $2.89M.

Biography of SAHA SAURABH

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$254,07915
Sells
$12,310,0822095

Comparison of Insiders on Amount of Buys and Sells

2025-03-20SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
55,000
0.0428%
$16.69$918,060-6.88%
2025-03-03PurchaseClarivate Plc
CLVT
director
58,275
0.0088%
$4.36$254,079-2.13%
2025-02-20SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
55,000
0.0418%
$15.93$876,088+2.46%
2025-01-21SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
55,000
0.0401%
$15.77$867,430+0.3%
2024-12-20SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
55,000
0.0422%
$17.44$959,057-3.79%
2024-12-06SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
87,496
0.0665%
$18.46$1.62M-10.66%
2024-11-25SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
299
0.0002%
$18.23$5,451-2.05%
2024-11-22SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
1,671
0.0015%
$18.24$30,478-1.64%
2024-11-21SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
3,511
0.0027%
$18.24$64,028-7.81%
2024-11-20SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
55,000
0.0424%
$16.89$928,719+0.21%
2024-11-13SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
32,023
0.0284%
$18.28$585,419-7.25%
2024-10-23SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
2,592
0.0023%
$15.32$39,697+10.46%
2024-10-22SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
30,203
0.027%
$15.67$473,169+8.21%
2024-10-21SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
22,205
0.0196%
$15.80$350,861+5.79%
2024-09-20SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
55,000
0.0484%
$16.53$908,985-0.69%
2024-09-10SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
175,000
0.1752%
$16.52$2.89M+12.89%
2024-08-30SaleClarivate Plc
CLVT
director
17,646
0.0024%
$6.75$119,111-24.2%
2024-08-23SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
46,651
0.0395%
$12.30$573,905+27%
2024-08-22SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
506
0.0004%
$12.23$6,188+33.69%
2024-08-21SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
3,674
0.0033%
$12.25$44,989+33.5%
Total: 24
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.